Emerging and established modes of cell death during acetaminophen-induced liver injury

Hartmut Jaeschke1, Anup Ramachandran2, Xiaojuan Chao2

  • 1Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1018, Kansas City, KS, 66160, USA. hjaeschke@kumc.edu.

Archives of Toxicology
|October 24, 2019
PubMed

Insights

Acetaminophen (APAP) causes liver injury through programmed necrosis, not other cell death types. Understanding APAP hepatotoxicity mechanisms is key for developing treatments.

Area of Science:

  • Hepatology
  • Toxicology
  • Cell Biology

Background:

  • Acetaminophen (APAP)-induced liver injury is a significant clinical issue.
  • Identifying cell death mechanisms is crucial for therapeutic development.

Purpose of the Study:

  • To review APAP hepatotoxicity mechanisms.
  • To compare APAP-induced cell death with emerging cell death modalities.

Main Methods:

  • Review of experimental and clinical evidence on APAP hepatotoxicity.
  • Comparison of APAP-induced cell death features with apoptosis, necroptosis, ferroptosis, pyroptosis, and autophagic cell death.

Main Results:

  • APAP hepatotoxicity involves mitochondrial dysfunction, oxidant stress, and DNA fragmentation.
  • Features suggest programmed necrosis, with some overlap with other cell death types.
  • APAP-induced cell death does not fully align with apoptosis, necroptosis, ferroptosis, pyroptosis, or autophagic cell death.

Conclusions:

  • APAP-induced liver injury is best characterized as programmed necrosis.
  • This classification is based on the preponderance of evidence, despite some shared features with other cell death pathways.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.2K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.2K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
154
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
13.8K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
189
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
829